Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.
Chicago, IL – January 8, 2025– Today, Zacks Investment Ideas feature highlights Advanced Micro Devices AMD and Nike NKE.
Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...
In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...
Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...